Potentiation of warfarin anticoagulation associated with topical methyl salicylate

Ann Pharmacother. 2000 Jun;34(6):729-33. doi: 10.1345/aph.19309.

Abstract

Objective: To report a case of international normalized ratio (INR) elevation resulting from the administration of topical methyl salicylate in a patient whose INR was previously stable while she received warfarin anticoagulation.

Case summary: A 22-year-old white woman presented with an INR of 12.2 after applying a topical pain-relieving gel to her knees daily for eight days. The potentiation of the warfarin anticoagulation was attributed to the low-dose methyl salicylate contained in the product.

Discussion: Methyl salicylate is systemically absorbed through the skin in measurable amounts, and may increase warfarin action by affecting vitamin K metabolism or by displacing warfarin from protein-binding sites. While several investigators have reported this interaction with use of high-dose methyl salicylate, this case indicates that a significant interaction can occur with the use of lower topical doses of methyl salicylate as well.

Conclusions: Healthcare providers and patients taking warfarin must be aware of the potential hazard of using topical methyl salicylate in combination with warfarin.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adult
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics*
  • Drug Synergism
  • Female
  • Fixatives / adverse effects
  • Fixatives / pharmacokinetics*
  • Hemorrhage / chemically induced
  • Humans
  • International Normalized Ratio*
  • Ointments / adverse effects
  • Ointments / pharmacokinetics
  • Salicylates / adverse effects
  • Salicylates / pharmacokinetics*
  • Warfarin / adverse effects
  • Warfarin / pharmacokinetics*

Substances

  • Anticoagulants
  • Fixatives
  • Ointments
  • Salicylates
  • Warfarin
  • methyl salicylate